
Tarsus Pharmaceuticals, Inc. (($TARS)) has held its Q3 earnings call. Read on for the main highlights of the call. Tarsus Pharmaceuticals delivered a strongly positive earnings call, driven by record
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 77.88 | -1.19 | -1.50% |
| Name | Price | % Change | |
|---|---|---|---|
| $77.88 | -1.50% |

Tarsus Pharmaceuticals, Inc. (($TARS)) has held its Q3 earnings call. Read on for the main highlights of the call. Tarsus Pharmaceuticals delivered a strongly positive earnings call, driven by record

Mizuho analyst Graig Suvannavejh raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $102 from $94 and keeps an Outperform rating on the shares. Published first on TheFly –

Guggenheim raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $97 from $89 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source

Oppenheimer raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $103 from $100 and keeps an Outperform rating on the shares. The firm notes the company’s Q3 beat and

H.C. Wainwright raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $106 from $88 and keeps a Buy rating on the shares. The company reported an “impressive” record $194.6M

Reports Q3 revenue $194.57M, consensus $186.6M. “Ten years ago, we started Tarsus with the conviction that patients with overlooked diseases deserved better,” said Bobby Azamian, M.D., Ph.D., Chief Executive Officer

Tarsus Pharmaceuticals, Inc. (TARS) is scheduled to report 3rd quarter earnings on 11/03/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Tarsus Pharmaceuticals, Inc. to post earnings

Mizuho lowered the firm’s price target on Tarsus Pharmaceuticals (TARS) to $94 from $100 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source

Tarsus Pharmaceuticals (TARS) announced the appointment of Neera Clase as chief commercial officer, or CCO, effective Nov. 1. Clase has served as Tarsus’ interim chief commercial officer since July and

The yield on the 10-year Treasury note slipped below 5.2% for the first time in nearly two weeks on Tuesday, and yet sentiment in equities remained cautious, with little support
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Initiated | Sep 24, 2026 | ||||
| buy | Reiterated | Sep 8, 2026 | ||||
| buy | Reiterated | Aug 12, 2026 | ||||
| buy | Assigned | Aug 8, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $3.86B | $-0.28 | $210.76M | 1.07 | -5.00 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.